Drug companies in US spent millions pushing for weight loss drug approvals, investigative report findsBMJ 2015; 350 doi: https://doi.org/10.1136/bmj.h2138 (Published 22 April 2015) Cite this as: BMJ 2015;350:h2138
- Michael McCarthy
Since 2010, makers of diet drugs have spent more than $60m (£40m; €56m) on lobbying, medical society sponsorships, and payments to physicians to get their weight loss drugs to the market, says a joint investigative report by the medical news website MedPage Today and the Milwaukee Journal Sentinel.1
The size of the market is considerable: the US Centers for Disease Control and Prevention has estimated that over a third (34.9%; 78.6 million) of US adults are obese. The new report alleged that many efforts by drug companies have been aimed at pressuring the US Food and Drug …
Log in using your username and password
Log in through your institution
Register for a free trial to thebmj.com to receive unlimited access to all content on thebmj.com for 14 days.
Sign up for a free trial